Group 1 - Semtech (SMTC) shares have increased by 9.4% over the past four weeks, closing at $37.33, with a mean price target of $56.33 indicating a potential upside of 50.9% [1] - The average of 12 short-term price targets ranges from a low of $43 to a high of $68, with a standard deviation of $8.32, suggesting a potential increase of 15.2% to 82.2% from the current price [2] - Analysts show strong agreement in revising earnings estimates higher, with a 20.4% increase in the Zacks Consensus Estimate for the current year, indicating positive sentiment towards SMTC's earnings prospects [11][12] Group 2 - The Zacks Rank for SMTC is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] - While price targets are a common metric, they should be approached with skepticism as they can often mislead investors, and analysts may set overly optimistic targets due to business incentives [3][7][10] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9]

Core Viewpoint - Backblaze, Inc. (BLZE) shows significant potential for upside, with a mean price target of $10.83 indicating a 90% upside from the current price of $5.70 [1] Price Targets - The average price target consists of six estimates ranging from a low of $8 to a high of $14, with a standard deviation of $1.94, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a potential increase of 40.4%, while the highest suggests a 145.6% upside [2] Analyst Sentiment - Analysts exhibit strong agreement regarding BLZE's ability to report better earnings than previously predicted, which supports the view of potential upside [4] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 4%, with four estimates moving higher and no negative revisions [12] Zacks Rank - BLZE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - This rank, along with a strong externally-audited track record, serves as a conclusive indicator of the stock's potential upside in the near term [13] Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be wise due to the questionable ability and unbiasedness of analysts in setting these targets [3][7] - Analysts often set overly optimistic price targets influenced by business relationships, which can lead to inflated estimates [8]

Pan American Silver (PAAS) closed the last trading session at $24.20, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $31.23 indicates a 29.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $4.44. While the lowest estimate of $26 indicates a 7.4% increase from the current price level, the most optimistic analyst ...

Core Viewpoint - Eastern Bankshares, Inc. (EBC) shows potential for significant upside, with a mean price target of $19.25 indicating a 30.2% increase from the current price of $14.78 [1] Price Targets and Analyst Consensus - The average price targets for EBC range from a low of $16 to a high of $23, with a standard deviation of $2.99, suggesting a moderate agreement among analysts [2] - The lowest estimate indicates an 8.3% increase, while the highest suggests a 55.6% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts are optimistic about EBC's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.4% over the past month, with three estimates revised upward and no negative revisions [12] - EBC holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13]

Core Viewpoint - Barrick Gold (B) shows potential for significant upside, with a mean price target of $24.39 indicating a 27.9% increase from the current price of $19.07 [1] Price Targets - The average of 16 short-term price targets ranges from a low of $21 to a high of $30.96, with a standard deviation of $2.90, suggesting a variability in estimates [2] - The lowest estimate indicates a 10.1% increase, while the highest suggests a 62.4% upside [2] Analyst Sentiment - Analysts are optimistic about Barrick Gold's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with potential stock price movements [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.2% over the past month, with three estimates revised higher and no negative revisions [12] Zacks Rank - Barrick Gold holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Group 1 - The core viewpoint is that Benitec Biopharma Limited (BNTC) has significant upside potential, with a mean price target of $25.71 indicating an 83.9% increase from its current price of $13.98 [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $6.70, suggesting variability in analyst predictions; the lowest estimate is $17 (21.6% increase), while the highest is $35 (150.4% increase) [2] - Analysts show strong agreement on BNTC's ability to report better earnings than previously predicted, which supports the expectation of stock upside [4][11] Group 2 - The Zacks Consensus Estimate for BNTC has increased by 15.6% due to three upward revisions in earnings estimates over the last 30 days, with no negative revisions [12] - BNTC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] - While price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Oportun Financial Corporation (OPRT) closed the last trading session at $6.90, gaining 57.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $9.04 indicates a 31% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $1.70. While the lowest estimate of $6.50 indicates a 5.8% decline from the current price level, the most optimistic ...

Core Viewpoint - Backblaze, Inc. (BLZE) shares have increased by 13.4% in the past four weeks, closing at $5.32, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $10.83, representing a 103.6% upside [1] Price Targets - The average price targets from analysts range from a low of $8 to a high of $14, with a standard deviation of $1.94, indicating variability in estimates; the lowest estimate suggests a 50.4% increase, while the highest points to a 163.2% upside [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates - Analysts have shown increasing optimism about BLZE's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 3.3% over the past month, with four estimates increasing and no negative revisions [12] Zacks Rank - BLZE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside in the near term [13]

Inspired Entertainment (INSE) closed the last trading session at $8.17, gaining 12.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.40 indicates a 51.8% upside potential.The average comprises five short-term price targets ranging from a low of $10 to a high of $16, with a standard deviation of $2.30. While the lowest estimate indicates an increase of 22.4% from the current pr ...

Group 1 - Shares of Adaptive Biotechnologies (ADPT) have increased by 5.1% over the past four weeks, closing at $8.81, with a mean price target of $11.14 indicating a potential upside of 26.5% [1] - The average price targets from analysts range from a low of $9 to a high of $13, with a standard deviation of $1.57, suggesting a variability in estimates; the lowest estimate indicates a 2.2% increase, while the highest points to a 47.6% upside [2] - Analysts show strong agreement in revising earnings estimates higher for ADPT, which correlates with potential stock price movements, as the Zacks Consensus Estimate for the current year has increased by 5.5% over the past month [4][12] Group 2 - ADPT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside in the near term [13] - The consensus price target, while not entirely reliable, suggests a positive direction for ADPT's price movement, supported by the recent upward revisions in earnings estimates [11][13]